Maxwell Biotech Venture Fund Invests in Pivotal Clinical Trial of Oxagen Limited’s Drug Candidate for Asthma Treatment
10/4/2012 10:26:12 AM
More...
|
Oxagen Limited Announces Completion of Recruitment in Phase IIb Dose Range-Finding Clinical Trial in New Oral Treatment for Asthma
12/9/2009 9:42:26 AM
More...
|
Oxagen Limited Raises £16 Million in Series C Private Venture Capital Financing Led by Novartis Venture Funds
11/24/2009 6:46:33 AM
More...
|
Oxagen Limited Announces The Appointment Of David U'Prichard As Non-Executive Chairman
10/19/2005 5:11:14 PM
More...
|
Oxagen Limited Raises $59.8 Million In Series B Private Venture Capital Financing Led By MPM Capital
10/19/2005 5:09:51 PM
More...
|
Oxagen Limited Raises $60 Million In Series B
10/19/2005 5:09:50 PM
More...
|